Page 15 - hypertension_newsletter9
P. 15
REFLECTIONS
Hypertension
Hypertension Global Newsletter #9 2025
ARTICLES OF INTEREST Hypertension
GUIDELINES AND POSITION STATEMENTS
1. Clinical staging to guide management of metabolic disorders and their sequelae: A European Atherosclerosis
Society consensus statement. Romeo S, et al. Eur Heart J. 2025 May:ehaf314. doi: 10.1093/eurheartj/ehaf314. Online
ahead of print.
2. Automated office blood pressure measurement: A Hypertension Australia and National Hypertension
Taskforce of Australia position statement. Sharman JE, et al. J Hypertens. 2025 Sep;43(9):1463-1472. doi: 10.1097/
HJH.0000000000004079. Epub 2025 Jun 18.
3. Hypertension and the gut microbiome: A science advisory from the American Heart Association. Yang T, et al.
Hypertension. 2025 Sep;82(9):e160-e170. doi: 10.1161/HYP.0000000000000247. Epub 2025 Jul 17.
4. Priorities for research on hypertension care delivery: A WHO report executive summary. Matsushita K, et al.
Hypertension. 2025 Jun;82(6):971-976. doi: 10.1161/HYPERTENSIONAHA.125.24702. Epub 2025 Mar 20.
TREATMENT
5. Incretin-based therapies: A paradigm shift in blood pressure management? Dreher L, et al. Hypertension. 2025
Jul;82(7):1167-1174. doi: 10.1161/HYPERTENSIONAHA.125.25112. Epub 2025 May 23.
6. Breaking down resistance: Novel aldosterone synthase inhibitors in the management of resistant hypertension.
Chung Hung CE, et al. J Hypertens. 2025 Aug;43(8):1286-1295. doi: 10.1097/HJH.0000000000004055. Epub 2025 May 14.
7. Changing the paradigm of long-term blood pressure control: A systematic review of novel therapies. Gnanenthiran
SR, et al. J Hypertens. 2025 Jun;43(6):917-928. doi: 10.1097/HJH.0000000000003984. Epub 2025 Feb 12.
8. Antihypertensive drug treatment: Are we ready for the future? Danser AHJ, Deinum J. J Hypertens. 2025
Jul;43(7):1099-1107. doi: 10.1097/HJH.0000000000004019. Epub 2025 Apr 1.
9. Efficacy and safety of aldosterone synthase inhibitors for hypertension: A meta-analysis of randomized
controlled trials and systematic review. Marzano L, et al. Hypertension. 2025 Apr;82(4):e47-e56. doi: 10.1161/
HYPERTENSIONAHA.124.23962. Epub 2025 Jan 31.
TARGETS AND MEASUREMENT
10. Role of inflammatory biomarkers in mediating causal effect of life course body comparison on hypertension. Fu L,
et al. Hypertension. 2025 Apr;82(4):e57-e69. doi: 10.1161/HYPERTENSIONAHA.124.24542. Epub 2025 Feb 12.
11. Intensive blood-pressure control in patients with type 2 diabetes. Bi Y, et al. N Engl J Med. 2025 Mar 27;392(12):1155-
1167. doi: 10.1056/NEJMoa2412006. Epub 2024 Nov 16.
12. Cuffless blood pressure measurement devices- International perspectives on accuracy and clinical use: A
narrative review. Yang E, et al. JAMA Cardiol. 2025 Jun 1;10(6):624-631. doi: 10.1001/jamacardio.2025.0662.
TABLE OF CONTENTS
